Investigational Product Supply and Use Authorization Agreement for OT-101 U.S. Expanded Access (IPSUA) between WideTrial and OncotelicAgreement • September 10th, 2019 • Mateon Therapeutics Inc • Pharmaceutical preparations • Delaware
This Agreement is made and entered into on September 5th, 2019 (the “Effective Date”), by and between WideTrial, Inc., a corporation headquartered at 8 The Green, Suite 8298, Dover, DE 19901 (“WideTrial) (the “Sponsor”), and Oncotelic Inc., headquartered at 29397 Agoura Rd., Ste 107, Agoura Hills, CA 91301 (“Oncotelic”) (the “Manufacturer”)(each a “Party”, collectively “Parties” to this bilateral Agreement).
Agreement for Delivery and Licensed Use of Data Generated from OT-101 U.S. Expanded Access (Data License 1 Agreement) between WideTrial and OncotelicMateon Therapeutics Inc • September 10th, 2019 • Pharmaceutical preparations • Delaware
This Agreement is made and entered into on September 5, 2019 (the “Effective Date”), by and between WideTrial Inc., a corporation headquartered at 8 The Green, Suite 8298, Dover, DE 19901 (“WideTrial) (the “Licensor”), and Oncotelic Inc., headquartered at 29397 Agoura Rd. Ste 107, Agoura Hills, CA 91301 (“Oncotelic”) (the “Licensee”) (each a “Party”, collectively “Parties” to this bilateral Agreement).
Agreement for Delivery and Licensed Use of WideTrial Bonus Dataset (Data License 2 Agreement) between WideTrial and OncotelicAgreement • September 10th, 2019 • Mateon Therapeutics Inc • Pharmaceutical preparations • Delaware
This Agreement is made and entered into on September 5, 2019 (the “Effective Date”), by and between WideTrial Inc., a corporation headquartered at 8 The Green, Suite 8298, Dover, DE 19901 (“WideTrial) (the “Licensor”), and Oncotelic Inc., headquartered at 29397 Agoura Rd. Ste 107, Agoura Hills, CA 91301 (“Oncotelic”) (the “Licensee”) (each a “Party”, collectively “Parties” to this bilateral Agreement).
